Biotechnology Expert Witnesses

Internal Medicine, Oncology - patents, biotechnology, pharmaceutical industry, internal medicine, oncology, endocrinology.

Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Order of Australia (Queen Elizabeth II) Biotechnology Company Founder

Internal Medicine, Oncology - patents, biotechnology, pharmaceutical industry, internal medicine, oncology, endocrinology.

Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Order of Australia (Queen Elizabeth II) Biotechnology Company Founder

Financial, Pediatric Hematology Oncology - Appraisal and Valuation, Banking, Business Valuation, DNA, Financial, Securities and Investments, Biotechnology, Medical Devices, Healthcare Services, Life Science Tools , Pharmaceuticals , Entrepreneurial Companies, Start-up companies

Ilonna Rimm can provide expert witness services related to valuation and financial analysis of Healthcare Companies, including Biotech, Medical Device, Healthcare Services and Life Science Tools companies. Ilonna Rimm, MD PhD CFA, is a healthcare investor who provides strategic advice on raising early-stage capital. As the CEO and Founder of Morninglight Healthcare Capital, LLC, a family office, she invests in small cap public companies (0 to $4B market cap). She also serves as an Advisor to Life Sciences CEO’s who are raising a Seed or Series A Round of capital, as Rimm Healthcare Capital Advisory, LLC. She can fully understand the biological science of an emerging company. Then she can organize and polish the science to present it in a way that is attractive to life science investors. She recently provided services to Immuneering Corp., who raised a Series A round of $20M in January, 2020, and a Series B round of $62M in January, 2021. Immuneering is now a public company (IM...

Biomedical Engineering, Gastroenterology - Diabetes, Obesity, Inflammatory bowel disease, IBD, Stem cells, Bariatric surgery, Microfluidics, Drug screening, Biotechnology, Organoids

I am an Associate Professor at Harvard Medical School, Massachusetts General Hospital, and Shriners Hospital. I received my Ph.D. in Biomedical Engineering and have a well-established record of research in several research areas, including stem cells, gastroenterology, and metabolism (diabetes and obesity). My laboratory's research has been published in leading scientific journals such as Science, Nature Medicine, and Gastroenterology. I also have a successful track record of funding from both federal agencies (such as NIH) and private organizations (including small and large biotech and biopharma companies). I have also frequently served as a consultant for various companies.

Regenerative Medicine, Biomedical Engineering - Regenerative Medicine, Cellular Therapies, Stem Cells, Extracellular Matrix, Perinatal Tissues (Placenta, Amnion, Chorion, Umbilical Cord Blood/Tissue), Transplantation, Cellular & Tissue Engineering, Biotechnology, Bioengineering, Medical Devices, Tissue Processing/Banking, HSCs, MSCs

Dr. Rouzbeh R. Taghizadeh has dedicated more than 20 years to bringing stem cell-based therapies to clinical practice. His expertise in adult stem cells, primarily human hematopoietic and mesenchymal stem cells—the regenerative cells involved in successful bone marrow and umbilical cord blood transplantations—uniquely positions him to approach science and business with the same keen powers of insight that have consistently reaped success surmounting scientific and medical barriers in the field. He earned his Ph.D. in Stem Cell Bioengineering in 2006 from the Massachusetts Institute of Technology (MIT) and co-founded AuxoCell Laboratories, Inc. as Chief Scientific Officer in 2008 after completing his post-doctoral training from MIT and the Boston Biomedical Research Institute. At MIT, in the laboratory of Dr. James L. Sherley, Dr. Taghizadeh focused on developing novel technologies to preferentially expand human hematopoietic stem cells ex vivo, a long-standing challenge faced by b...

Internal Medicine, Oncology - patents, biotechnology, pharmaceutical industry, internal medicine, oncology, endocrinology.

Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Order of Australia (Queen Elizabeth II) Biotechnology Company Founder

Pharmaceutical Research, Chemistry & Chemicals - Drug Formulation, Biotechnology, liquid formulation, medicinal chemist, organic chemist, pharmcokinetics, stability studies, dietary supplements, tetracyclines, synthetic biology, breathalyzer, drug tests

EXPERT WITNESS CONSULTING Dr Abato has been involved in 8 cases, been deposed 5 times and has testified at trial in 4 cases. Dr Abato has testified in high stakes litigation cases at the International Trade Commission and federal courts for major players in the pharmaceutical industry. He has experience with ANDA, trade secret, trademark infringement, patent infringement and contract law cases relating to pharmaceuticals. Upload Dr Abato’s CV, which includes a complete list of case numbers and Law Firms that he has represented. PHARMACEUTICAL EXPERIENCE Dr. Abato is a Medicinal Chemist. His expertise includes drug research, medicinal chemistry, organic chemistry, drug formulation for; IT, IV, IP, ICV, IN, IM and oral dosing routs, stability studies, extensive structure-activity relationships, efficacy, pharmacokinetics, as well as all pre-clinical testing required for IND submission to the FDA. Dr Abato was awarded the prestigious “Heroes of Chemistry Award” by the Amer...